The report provides a detailed analysis essential for establishing an acrisorcin production plant. It encompasses all critical aspects necessary for acrisorcin production, including the cost of acrisorcin production, acrisorcin plant cost, acrisorcin production costs, and the overall acrisorcin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an acrisorcin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Acrisorcin is a topical anti-infective agent that is a combination of 9-aminoacridine and 4-hexylresorcinol. It works as a fungicide that is utilised in dermatological applications. It targets fungal skin infections through its dual antifungal and antibacterial properties that utilise 9-aminoacridine antimicrobial action and 4-hexylresorcinol's keratolytic and antiseptic effects.
It is used for superficial mycoses caused by yeast-like fungi, like tinea versicolor (pityriasis versicolor), because of Malassezia furfur. It is used in conditions like athlete's foot, ringworm, and other superficial mycoses, helping in skin disinfection without systemic absorption. Its common side effects include itching, redness, burning and stinging, dryness and scaling, temporary staining, papular rash, irritation, and photosensitivity, etc.
The market for acrisorcin is driven by its demand in the topical antifungal market. Its ability to target tinea versicolor caused by Malassezia furfur and other superficial mycoses contributes to its market growth. The growing antifungal resistance problems and interest in dual fungicidal-bactericidal action make it useful in dermatological applications.
The demand for effective topicals over synthetic alternatives, expanding dermatological research into combination therapies, and steady regional adoption boost its market. The industrial acrisorcin procurement is influenced by established supplier networks that provide custom synthesis and regulatory compliance for topical formulations. The raw material dependency in China and intermittent supply chain disruptions from global forecasting inaccuracies or raw material cost fluctuations impact its sourcing strategies.
Raw Material for Acrisorcin Production
According to the acrisorcin production plant project report, the key raw materials used in the production of acrisorcin include 9-aminoacridine and 4-hexylresorcinol.
Production Process of Acrisorcin
The extensive acrisorcin production cost report consists of the following major industrial production process:
- From 9-aminoacridine and 4-hexylresorcinol: The production process of acrisorcin involves combining equimolar amounts of 9-aminoacridine and 4-hexylresorcinol. 9-Aminoacridine is prepared via condensation reactions or from acridine precursors. 4-hexylresorcinol is synthesised industrially through Friedel-Crafts acylation of resorcinol with hexanoyl chloride using Lewis acids like AlCl3. This is followed by Clemmensen or Wolff-Kishner reduction of the resulting 4-hexylresorcinol ketone. The mixture is formulated into creams or ointments for dermatological use.
Acrisorcin has the molecular formula of C25H28N2O2 and a molecular weight of 388.5 g/mol. It is a 1:1 mixture of the compound of 9-aminoacridine and 4-hexylresorcinol. It appears as yellow crystals with the topological polar surface area of 79.4 Ų. It has 3 H-bond donors, 4 acceptors, and 5 rotatable bonds. Its properties are influenced by 4-hexylresorcinol's solubility in water/ether/alcohol, faint odour, and sweet-bitter taste. It has a white crystalline form turning pink in light with a density of 1.1 g/cm³. It shows antifungal and keratolytic action via acridine's cationic disruption and resorcinol's phenol-like activity.